SAN FRANCISCO (Reuters Health) May 22 –
Fecal incontinence among scleroderma patients may be aided by sacral nerve stimulation delivered by an implanted neurostimulator, researchers reported Tuesday at Digestive Disease Week and the 103rd annual meting of the American Gastroenterological Association meeting that is underway here.
“These early results are encouraging,” said lead author Dr. Michael A. Kamm, a professor of gastroenterology at St. Marks Hospital in Harrow, England, and a consultant for the device’s manufacturer, Minneapolis-based Medtronic, Inc. “It’s a very effective therapy for
incontinence.”
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!